A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library

ABSTRACT Deep sequencing and single-chain variable fragment (scFv) yeast display methods are becoming more popular for discovery of therapeutic antibody candidates in mouse B cell repertoires. In this study, we compare a deep sequencing and scFv display method that retains native heavy and light chain pairing with a related method that randomly pairs heavy and light chain. We performed the studies in a humanized mouse, using interleukin 21 receptor (IL-21R) as a test immunogen. We identified 44 high-affinity binder scFv with the native pairing method and 100 high-affinity binder scFv with the random pairing method. 30% of the natively paired scFv binders were also discovered with the randomly paired method, and 13% of the randomly paired binders were also discovered with the natively paired method. Additionally, 33% of the scFv binders discovered only in the randomly paired library were initially present in the natively paired pre-sort library. Thus, a significant proportion of “randomly paired” scFv were actually natively paired. We synthesized and produced 46 of the candidates as full-length antibodies and subjected them to a panel of binding assays to characterize their therapeutic potential. 87% of the antibodies were verified as binding IL-21R by at least one assay. We found that antibodies with native light chains were more likely to bind IL-21R than antibodies with non-native light chains, suggesting a higher false positive rate for antibodies from the randomly paired library. Additionally, the randomly paired method failed to identify nearly half of the true natively paired binders, suggesting a higher false negative rate. We conclude that natively paired libraries have critical advantages in sensitivity and specificity for antibody discovery programs.

[1]  Robert C. Edgar,et al.  Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics , 2017, mAbs.

[2]  R. Edgar,et al.  Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics , 2017, mAbs.

[3]  Lin Sun,et al.  Deciphering antigen-responding antibody repertoires by using next-generation sequencing and confirming them through antibody-gene synthesis. , 2017, Biochemical and biophysical research communications.

[4]  P. Lipsky,et al.  Mechanisms That Shape Human Antibody Repertoire Development in Mice Transgenic for Human Ig H and L Chain Loci , 2017, The Journal of Immunology.

[5]  Adam Miles,et al.  Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another , 2017, PloS one.

[6]  C. Clegg,et al.  Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice. , 2016, Antiviral research.

[7]  A. Ellington,et al.  Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH:VL libraries from immunized animals , 2016, mAbs.

[8]  Jeffrey J. Gray,et al.  Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires , 2016, Proceedings of the National Academy of Sciences.

[9]  Andrew D. Ellington,et al.  Corrigendum: Facile Discovery of a Diverse Panel of Anti-Ebola Virus Antibodies by Immune Repertoire Mining , 2016, Scientific Reports.

[10]  T. Wilkinson,et al.  Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope “tags” , 2014, mAbs.

[11]  George Georgiou,et al.  In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire , 2014, Nature Medicine.

[12]  Adam R Miles,et al.  High-Throughput Epitope Binning Assays on Label-Free Array-Based Biosensors Can Yield Exquisite Epitope Discrimination That Facilitates the Selection of Monoclonal Antibodies with Functional Activity , 2014, PloS one.

[13]  S. Reddy,et al.  Using next-generation sequencing for discovery of high-frequency monoclonal antibodies in the variable gene repertoires from immunized mice. , 2014, Methods in molecular biology.

[14]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[15]  Narayan Jayaram,et al.  Germline VH/VL pairing in antibodies. , 2012, Protein engineering, design & selection : PEDS.

[16]  George Georgiou,et al.  Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining. , 2012, Protein engineering, design & selection : PEDS.

[17]  M. Shlomchik,et al.  Germinal center selection and the development of memory B and plasma cells , 2012, Immunological reviews.

[18]  R. Brink,et al.  Affinity‐based selection and the germinal center response , 2012, Immunological reviews.

[19]  J. Reichert,et al.  Development trends for human monoclonal antibody therapeutics , 2010, Nature Reviews Drug Discovery.

[20]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[21]  Seung Hyun Kang,et al.  Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells , 2010, Nature Biotechnology.

[22]  Benjamin D. Sellers,et al.  Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains. , 2009, Journal of molecular biology.

[23]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[24]  N. Lonberg.  Fully human antibodies from transgenic mouse and phage display platforms. , 2008, Current opinion in immunology.

[25]  W. Leonard,et al.  Interleukin-21: basic biology and implications for cancer and autoimmunity. , 2008, Annual review of immunology.

[26]  Kouhei Tsumoto,et al.  Critical contribution of VH–VL interaction to reshaping of an antibody: The case of humanization of anti‐lysozyme antibody, HyHEL‐10 , 2008, Protein science : a publication of the Protein Society.

[27]  M. Hegen,et al.  Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[28]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[29]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[30]  R M Hoet,et al.  Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. , 1999, Journal of molecular biology.

[31]  R. Brezinschek,et al.  Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. , 1998, Journal of immunology.

[32]  R L Brady,et al.  VL:VH domain rotations in engineered antibodies: Crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs , 1997, Proteins.

[33]  Jeffrey Crosbie,et al.  Induction of self-tolerance in mature peripheral B lymphocytes , 1989, Nature.

[34]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.